| 000 | 00913 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513001535.0 | ||
| 264 | 0 | _c19810810 | |
| 008 | 198108s 0 0 eng d | ||
| 022 | _a0379-0363 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDi Rosa, M | |
| 245 | 0 | 0 |
_aAssessment of anti-inflammatory drugs: clinical aspects. Introductory remarks. _h[electronic resource] |
| 260 |
_bAgents and actions. Supplements _c1980 |
||
| 300 |
_a245-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArachidonic Acids _xmetabolism |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aCapillary Permeability |
| 650 | 0 | 4 | _aCell Migration Inhibition |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aLeukocytes _ximmunology |
| 773 | 0 |
_tAgents and actions. Supplements _gvol. 7 _gp. 245-6 |
|
| 999 |
_c6941362 _d6941362 |
||